Artia Global Partners LP Biomarin Pharmaceutical Inc Transaction History

Artia Global Partners LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$76.22 - $98.51 $3.78 Million - $4.88 Million	-49,580 Reduced 63.19%	28,885 $2.79 Billion
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $3.47 Million - $4.01 Million	-40,000 Reduced 33.77%	78,465 $6.8 Billion
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $7.92 Million - $10.6 Million	90,248 Added 319.84%	118,465 $11.5 Billion
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $2.28 Million - $3.07 Million	28,217 New	28,217 $2.92 Billion

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Artia Global Partners LP, based on Form 13F filings with the SEC.

Stay updated on Artia Global Partners LP with notifications on news.